We have highlighted the following papers, which evaluate various aspects of the UK's salt reduction programme.
- An executive summary of a new legal analysis, conducted by Prof Amandine Garde and Dr Oliver Bartlett
Click to view: Rethinking the UK Salt Reduction Policy [PDF 113KB]
Excessive salt consumption is associated with a number of NCDs, including cardiovascular disease, hypertension, and raised blood pressure and cholesterol. While UK policy has been relatively successful to date in reducing the overall salt consumption of the population, there is scope for a more multifaceted approach that would lead to significant public health gains. This paper analyses the role that law-based interventions could play in salt reduction policy.
By explicitly grounding measures in the rights of individuals to enjoy health-promoting environments, especially where the measure aims at the protection of children, states will be in an even stronger position to counter trade and fundamental rights based legal challenges, and may even dissuade some of these challenges entirely.
- Quantifying the impact of the Public Health Responsibility Deal on salt intake, cardiovascular disease and gastric cancer burdens: interrupted time series and microsimulation study (abstract)
Anthony A Laverty, PhD; Christ Kypridemos; Paraskevi Seferidi; Eszter Vamos; Jonathan Pearson-Stuttard; Brendan Collins; Simon Capewell; Modi Mwatsama; Paul Cairney; Kate Fleming; Martin O'Flaherty; Christopher Millett.
Public-Private Partnerships (PPPs) are increasingly promoted as a key mechanism to improve population health, including addressing dietary risk factors for non-communicable disease. In 2011, England introduced the Public Health Responsibility Deal (RD), a PPP which gave greater freedom to the food industry to set and monitor targets for sodium intakes, and replaced an internationally recognised scheme involving more independent scrutiny. We estimated the impact of the RD on trends in population level sodium intake and associated changes in cardiovascular disease (CVD) and gastric cancer (GCa) incidence and mortality and their economic costs in England from 2011-2025.